Acticor Biotech Aktie
0,28EUR | -0,01EUR | -3,75% |
WKN DE: A3C6GM / ISIN: FR0014005OJ5
Aktionärsstruktur
Inhaber | in % |
---|---|
Afer - Flore | 0,95 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 14 | 18 | 25 | 21 | 28 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 14 | 10 | 17 | 12 | 9 |
Summe Anlagevermögen | 1 | 1 | 1 | 1 | 0 |
Summe Aktiva | 15 | 11 | 18 | 13 | 10 |
Bilanz (in Mio. EUR) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 1 | 3 | 3 | 8 | 6 |
Summe Fremdkapital | 6 | 9 | 7 | 15 | 15 |
Summe Eigenkapital | 9 | 2 | 11 | -2 | -5 |
Summe Passiva | 15 | 11 | 18 | 13 | 10 |
Adresse
Wojo Building, 75014 Paris | |
Telefon | +33 (7) 76-23-38-13 |
Internet | http://www.acticor-biotech.com |
Management
Adeline Meilhoc
Head-Global Clinical Development |
Alain H. Munoz
Chairman |
Alain Parthoens
Director |
Andrea Comenducci
Senior Director-Medical |
Anouar Sari
Head-Clinical Operations |
Antoine Lebel
Communication Assistant |
Aymeric Humblot
Head-Finance & Administration |
Catherine Boule
Director |
Elsa Sirou
Senior Manager-Regulatory Affairs |
Francois Guillet
Chief Financial Officer |
Gilles Avenard
Chief Executive Officer & Director |
Guy Heynen
Director |
Hervé Bachelot Lallier
Director |
James Stearns
Observer |
Jean-Pierre Cazenave
Independent Director |
Jessica Jami
Manager-Regulatory Affairs |
Leila Nicolas
Director |
Patricia Zilliox
Independent Director |
Philippe Billiald
Scientific Founder |
Rinaldo del Bono
Director |
Sirine Bougamra
Medical Director |
Sophie Binay
General Manager & Chief Scientific Officer |
Yannick Plétan
Chief Medical Officer & General Manager |